Submit Manuscript

International Journal of Pharmacology

Year: 2006 | Volume: 2 | Issue: 4 | Page No.: 388-393
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend

Total views 118

Authors

Sepideh Arbabi Bidgoli

Bagher Minaee

Mansoor Djamali Zavarehi

Shamileh Fouladdel

Ebrahim Azizi

Keywords

Comparative study of markers of drug resistance in cancer tissues may be extremely helpful in selection of effective chemotherapeutic regimen. P-glycoprotein (P-gp) and Topoisomerase II α (Topo II α) are two fundamental proteins in multi-drug resistance phenomenon (MDR). This study determined the expression and significance of P-gp and Topo II α proteins in advanced gastric carcinomas and correlated molecular alterations with clinicopathological findings. Tissue samples of 35 patients with advanced type gastric adenocarcinoma were analyzed. Immunohistochemical techniques were applied using primary antibodies for P-gp or Topo II α and LSAB2 detection kit (Dako-Denmark). Positive immunostaining for P-gp and Topo II α were observed in 42.9% and 17.2% of tumor samples, respectively. Negative expressions of P-gp and TopoII were associated with sex (p = 0.035 and 0.0001) and histological grade (p = 0.021 and 0.0001), respectively. Unlike P-gp, an inverse relationship between Topo II α expression and size of tumors (p = 0.012) and lymphatic invasion (p = 0.013) were observed. Considering the key role of positive P-gp or negative Topo II α expression in MDR, it could be concluded that groups of patients with P-gp over expression (42.9%) or lack of Topo II α expression (82.8%) would less likely benefit from available chemotherapeutic regimens. Therefore, we highly recommend determination of tumor status for expression of tumor markers such as P-gp and Topo II α, before deciding about effective chemotherapeutic regimen for patients with gastric cancer.
PDF References Citation

How to cite this article

Sepideh Arbabi Bidgoli, Bagher Minaee, Mansoor Djamali Zavarehi, Shamileh Fouladdel and Ebrahim Azizi, 2006. P-glycoprotein and Topoisomerase II α Expression in Advanced Gastric Cancer Patients: Association with Clinicopathological Findings. International Journal of Pharmacology, 2: 388-393.

DOI: 10.3923/ijp.2006.388.393

URL: https://scialert.net/abstract/?doi=ijp.2006.388.393

Leave a Comment

Your email address will not be published. Required fields are marked *